scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference

BURLINGTON, Mass., March 01, 2018 -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer of scPharmaceuticals, will present at the Cowen 38^th Annual Health Care Conference at 10:40 a.m. ET on Wednesday, March 14, 2018, at the Boston Marriott Copley Plaza in Boston, MA.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the Company's website at www.scpharmaceuticals.com for ninety days. 

About scPharmaceuticals
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs. Our proprietary platform is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (IV) delivery.

Contacts:

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
[email protected]

Christopher F. Brinzey
Westwicke Partners, 339-970-2843
[email protected]